Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement
MAC-VITAL
1 other identifier
observational
200
1 country
4
Brief Summary
The impact of the coronavirus disease (COVID)-19 pandemic on global healthcare systems has prompted a search for novel tools to stem the tide. New digital health tools can provide possible health solutions in this time of unprecedented medical crisis to mitigate the impact of this pandemic. This proof of concept study will determine the feasibility and effectiveness of implementing a mobile application for contactless screening and vital signs measurement (MAC-VITAL) such as blood pressure (BP), heart rate (HR), respiratory rate (RR), oxyhemoglobin saturation (SpO2), temperature from surgical patients peri-operatively. Contactless measurement of vital signs will bridge the current gap between virtual care and in-person medical assessments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2021
CompletedFirst Posted
Study publicly available on registry
July 26, 2021
CompletedStudy Start
First participant enrolled
October 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2022
CompletedSeptember 14, 2021
September 1, 2021
1 year
July 15, 2021
September 8, 2021
Conditions
Outcome Measures
Primary Outcomes (7)
Systolic blood pressure difference from reference measurement (mmHg)
Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)
Perioperative
Diastolic blood pressure difference from reference measurement (mmHg)
Assessed against standard clinical grade instrument: automated oscillometric blood pressure device (mmHg)
Perioperative
Blood oxygenation (SpO2) difference from reference measurement (% oxyhemoglobin saturation)
Assessed against standard clinical grade instrument: Finger-based pulse oximeter (% oxyhemoglobin saturation)
Perioperative
Pulse rate difference from reference measurement (beats per minute)
Assessed against standard clinical grade instrument: Finger-based pulse oximeter (beats per minute)
Perioperative
Teperature difference from reference measurement (degrees Celsius)
Assessed against standard clinical grade instrument: Forehead digital thermometer (degrees Celsius)
Perioperative
Respiratory rate difference from reference measurement (breaths per minute)
Assessed against standard clinical grade instrument: Visual count of chest rise and fall (breaths per minute)
Perioperative
Obstacles to using the mobile application
Characterization of obstacles to the implementation of the mobile app for perioperative vital sign measurements.
Perioperative
Secondary Outcomes (5)
Detection rate of clinically meaningful changes of vital signs
Perioperative
Ease of use survey
Perioperative
Satisfaction survey
Perioperative
Study participation
Perioperative
Compliance with measurement protocol
Perioperative
Study Arms (1)
Perioperative patients
Patients undergoing perioperative assessment of vital signs.
Interventions
Collection of facial blood flow and temperature information via conventional and infrared/thermal video of the face for the purpose of estimating vital signs using machine learning-based computational models.
Eligibility Criteria
Patients scheduled to undergo elective surgery under general and/or regional anesthesia.
You may qualify if:
- Patients scheduled to undergo elective surgery under general and/or regional anesthesia
- + years of age
You may not qualify if:
- Refusal to consent for the study
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nuralogix Corporationlead
- University Health Network, Torontocollaborator
- Hamilton Health Sciences Corporationcollaborator
Study Sites (4)
Hamilton General Hospital (Hamilton Health Sciences)
Hamilton, Ontario, L8L 2X2, Canada
Juravinski Hospital (Hamilton Health Sciences)
Hamilton, Ontario, L8V 1C3, Canada
Toronto General Hospital
Toronto, Ontario, M5G 2C4, Canada
Toronto Western Hospital, University Health Network
Toronto, Ontario, M5T 2S8, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Frances Chung, MBBS, FRCPC
University Health Network, Toronto
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 15, 2021
First Posted
July 26, 2021
Study Start
October 1, 2021
Primary Completion
October 1, 2022
Study Completion
October 1, 2022
Last Updated
September 14, 2021
Record last verified: 2021-09